Form 8-K - Current report:
SEC Accession No. 0001555280-25-000264
Filing Date
2025-10-09
Accepted
2025-10-09 16:24:08
Documents
14
Period of Report
2025-10-09
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K zts-20251009.htm   iXBRL 8-K 27093
2 EX-99.1 exhibit9914q2025dividendpr.htm EX-99.1 11962
6 GRAPHIC image_0a.jpg GRAPHIC 16150
  Complete submission text file 0001555280-25-000264.txt   180233

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zts-20251009.xsd EX-101.SCH 1848
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT zts-20251009_lab.xml EX-101.LAB 21880
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT zts-20251009_pre.xml EX-101.PRE 12574
16 EXTRACTED XBRL INSTANCE DOCUMENT zts-20251009_htm.xml XML 2695
Mailing Address 10 SYLVAN WAY PARSIPPANY NJ 07054
Business Address 10 SYLVAN WAY PARSIPPANY NJ 07054 973-822-7000
Zoetis Inc. (Filer) CIK: 0001555280 (see all company filings)

EIN.: 460696167 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)